{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:04:33Z","timestamp":1749182673351,"version":"3.41.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-142443"],"award-info":[{"award-number":["MOP-142443"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.1080\/02791072.2024.2338734","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T07:23:18Z","timestamp":1712647398000},"page":"149-162","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses"],"prefix":"10.1080","volume":"57","author":[{"given":"Tianna","family":"Magel","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes Atziri Gonzalez","family":"Arreola","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Guh","sequence":"additional","affiliation":[{"name":"St. Paul\u2019s Hospital","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Providence Crosstown Clinic","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Harrison","sequence":"additional","affiliation":[{"name":"Urban Health and Substance Use","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schechter","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"St. Paul\u2019s Hospital","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"St. Paul\u2019s Hospital","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2022.2040007"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00585-4"},{"key":"e_1_3_5_4_1","unstructured":"British Columbia Centre on Substance Use. 2021. Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder. https:\/\/www.bccsu.ca\/wp-content\/uploads\/2021\/07\/BC_iOAT_Guideline.pdf."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"e_1_3_5_6_1","unstructured":"Canadian Research Initiative in Substance Misuse. 2019. Injectable opioid agonist treatment for opioid use disorder clinical guideline.https:\/\/crism.ca\/projects\/ioat-guideline\/."},{"key":"e_1_3_5_7_1","unstructured":"Canadian Research Initiative in Substance Misuse. 2020. National injectable opioid agonist treatment guideline clinical guideline an operational guidance. https:\/\/crism.ca\/projects\/ioat-guideline."},{"key":"e_1_3_5_8_1","unstructured":"Chief Public Health Officer Health Professional Forum. 2023. Common definitions on cultural safety. Public Health Agency of Canada. https:\/\/www.canada.ca\/content\/dam\/hc-sc\/documents\/services\/publications\/health-system-services\/chief-public-health-officer-health-professional-forum-common-definitions-cultural-safety\/definitions-en2.pdf."},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2125.2012.04317.X"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/S00213-017-4814-3"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcnurse.2011.06.008"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.PUB4"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0140995"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1360-0443.2008.02334.X"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2012.10.025"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/S13011-019-0227-0"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-0253-y"},{"key":"e_1_3_5_20_1","unstructured":"Naber D. and P.D. Christian Haasen. 2006. The German Model Project for Heroin Assisted Treatment of Opioid Dependent Patients - A Multi-Centre Randomised Controlled Treatment Study. Germany: Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS). http:\/\/www.heroinstudie.de\/H-Report_P1_engl.pdf."},{"key":"e_1_3_5_21_1","unstructured":"Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique. 2004. Manuel Traitement avec prescription d\u2019h\u00e9ro\u00efne: Directives recommandations informations. Switzerland. www.admin.ch\/bag\/sucht\/f\/index.htm."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.02.021"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA0810635"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.0109"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2011.0078"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.03.012"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000505"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/10884600601174425"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304041"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.09.003"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149195"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1037\/A0022967"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7410.310"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2024.2338734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:56:26Z","timestamp":1749102986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2024.2338734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,15]]}},"alternative-id":["10.1080\/02791072.2024.2338734"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2024.2338734","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"type":"print","value":"0279-1072"},{"type":"electronic","value":"2159-9777"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}